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Introduction
Steroids, ubiquitous in living systems, constitute an important
group of terpenoid lipids with four cycloalkane rings arranged
in a specific gonane structure. They are found in eukaryotic
membranes and have diverse functions as signal molecules
(hormones, pheromones). Steroid hormones, for example, are
known to control various aspects of cell proliferation, tissue
differentiation and signal transduction pathways by binding to
specific receptors.[1] Therefore, steroids play an important role
as pharmaceuticals in, for example, endocrinology, oncology,
rheumatology, and gynecology. They represent the second
largest category of marketed medical products after antibiot-
ics.[2] The biological activity of steroids depends on their struc-
ture, the oxidation state of the ring system, and the type,
number, regio-, and stereo-position of functional groups at-
tached to the gonane nucleus. Even minor chemical changes
can substantially influence the physiological activity of steroids.
Hydroxylation is one of the most important reactions for mod-
ulating steroid function.[3–4] Hydroxylated steroids often have
increased biological activity compared to their less-polar, non-
hydroxylated analogues.[1] Chemical synthesis of hydroxylated
variants of steroids is challenging as it requires complicated
multistep synthetic pathways and has low overall yield and
high cost.[3] To the best of our knowledge, there is no report
on large-scale preparation of hydroxylated steroids by chemi-
cal synthesis.
Over the last years, biotechnological research in pharmacy
has focused on the structural modification of bioactive steroids
by using various microorganisms and their monooxygenases
as transformation agents (whole-cell biotransformations).[5–6]
Members of the cytochrome P450 monooxygenase superfamily
(P450s), which catalyzes the transfer of oxygen from O2 to a va-
riety of organic compounds, are responsible for selective ste-
roid oxyfunctionalizations.[7] In this context, enzymatic steroid
hydroxylation catalyzed by engineered P450 mutants (e.g. , of
BM3) has gained attention for the preparation of diverse and
unique hydroxylated steroids with pharmacological activity.[8, -9]
However, the use of isolated P450 for larger-scale application
is hampered by low activity, catalytic efficiency, and stability
outside cells, the requirement for NAD(P)H (as electron donat-
ing co-substrate), and the necessity for electron-transferring
partners.[10]
Unspecific peroxygenases (UPO, EC 1.11.2.1) secreted by fungi
open an efficient way to selectively oxyfunctionalize diverse
organic substrates, including less-activated hydrocarbons, by
transferring peroxide-borne oxygen. We investigated a cell-free
approach to incorporate epoxy and hydroxyl functionalities di-
rectly into the bulky molecule testosterone by a novel unspe-
cific peroxygenase (UPO) that is produced by the ascomyce-
tous fungus Chaetomium globosum in a complex medium rich
in carbon and nitrogen. Purification by fast protein liquid chro-
matography revealed two enzyme fractions with the same
molecular mass (36 kDa) and with specific activity of 4.4 to
12 U mg@1. Although the well-known UPOs of Agrocybe aegerita
(AaeUPO) and Marasmius rotula (MroUPO) failed to convert tes-
tosterone in a comparative study, the UPO of C. globosum
(CglUPO) accepted testosterone as substrate and converted it
with total turnover number (TTN) of up to 7000 into two oxy-
genated products: the 4,5-epoxide of testosterone in b-config-
uration and 16a-hydroxytestosterone. The reaction performed
on a 100 mg scale resulted in the formation of about 90 % of
the epoxide and 10 % of the hydroxylation product, both of
which could be isolated with purities above 96 %. Thus,
CglUPO is a promising biocatalyst for the oxyfunctionalization
of bulky steroids and it will be a useful tool for the synthesis of
pharmaceutically relevant steroidal molecules.
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For more than ten years, unspecific peroxygenases (UPOs,
EC 1.11.2.1) have gained attention in the field of oxyfunctional-
ization chemistry. They constitute a distinct (super)family of
fungal heme-thiolate proteins that catalyze efficient and selec-
tive oxygen-transfer from peroxides to diverse organic sub-
strates including non-activated compounds.[11] UPOs are rela-
tively stable and versatile biocatalysts, and combine the cata-
lytic cycle of heme peroxidases with the “peroxide shunt” of
P450s.[12, 13] The first UPO was discovered in the wood-dwelling
agaric fungus Agrocybe aegerita (AaeUPO); two similar enzymes
were described in the mushrooms Coprinellus radians (CraUPO)
and Marasmius rotula (MroUPO).[14–16] The reactions catalyzed
by these UPOs comprise aromatic and aliphatic hydroxylations
(including subsequent bond cleavages resulting in N- and O-
dealkylations), epoxidation, N-oxygenation, sulfoxidation, de-
chlorination, and halide oxidation.[11] Frequently, the product
patterns of UPOs resemble those of P450s, including various
human liver enzymes. UPOs have successfully been used as
oxygenation tools for the synthesis of human drug metabo-
lites.[17–19] The first detailed studies on steroid hydroxylation by
several UPOs revealed preferred accessibility of the hydropho-
bic C17 alkyl side chain to the substrate channel; the entrance
of whole rings was found to be energetically penalized, in
particular when the C3 position was already oxyfunctional-
ized.[17, 20, -21] Consequently, substrates, such as testosterone,
that lack an alkyl side chain or bearing oxidized C3 were not
converted.[20]
Over 2500 putative UPO sequences from all larger taxonom-
ic groups of fungi can be found in genetic databases; this has
encouraged the prospective extension of the UPO toolbox to
new synthetic applications including the oxyfunctionalization
of bulky steroids.[11–12, 22] A blastp search using known UPO ref-
erences (e.g. from Agrocybe aegerita B9W4V6) to the recently
published genome of the ubiquitous ascomycete fungus Chae-
tomium globosum (order Sordariales) revealed four sequences
encoding putative peroxygenases.[23] C. globosum is a cellulolyt-
ic fungus that colonizes a variety of materials in terrestrial and
marine environments.[24]
In this study, we investigated the major UPO of C. globosum
(CglUPO, XM_001219539.1). We describe its secretion during
fungal cultivation and purification, and its molecular and cata-
lytic characterization. Furthermore, oxyfunctionalization of tes-
tosterone by CglUPO resulted in the selective epoxidation of
the A ring of the gonane nucleus as well as in the hydroxyl-
ation of the D ring.
Results
UPO production by C. globosum
C. globosum produced an unspecific peroxygenase (CglUPO) in
carbon- and nitrogen-rich liquid medium. Changes in medium
composition led to considerable changes in productivity and
enzyme yield (data not shown). The maximum activity
(530 U L@1, based on a veratryl alcohol assay) was achieved
after 21 days of cultivation in 42 g L@1 glucose, 18 g L@1 pep-
tone, and 4.5 g L@1 yeast extract (secretion ~40 mg L@1 UPO
protein). Afterwards, UPO activity rapidly decreased within a
few days (Figure 1). During the cultivation process, C. globosum
progressively alkalified its medium: from pH 6.0 to pH 7.1
(day 11) and up to pH 8.9 on the last day of cultivation
(day 27). Fungal biomass consisted of pellets (3–5 mm diame-
ter) with a dry mass of 7.2 g L@1 around day 20. In contrast to
known UPO-producing strains, an accompanied laccase activity
was not detected under these culture conditions.[14–16] Laccase
was measured because it can hamper UPO purification.
Purification and characterization of CglUPO
Two fractions (I and II) obtained after elution of the concentrat-
ed culture liquid of 21-day-old cultures from a Mono Q column
(Figure S1 A in the Supporting Information) showed H2O2-de-
pendent activity towards veratryl alcohol at pH 7. The final
total activities were 191 and 292 U, respectively ; SDS-PAGE
revealed a molecular mass of 36 kDa for both fractions (Fig-
ure S1 B). As the specific activity of fraction II (12 U mg@1) was
three times higher than that of fraction I, it was used for physi-
cal and catalytic characterization. The UV/Vis spectrum of the
enzyme’s resting state demonstrated a typical UPO maximum
at 422 nm (Soret band) with a- and b-bands at 570 and
540 nm (Figure S1 C).
The published C. globosum genome sequence contains four
UPO genes.[23] We identified CglUPO as CHGG_00 319 (XM_
001219539.1) as the purified enzyme by using a proteomic
approach (peptide mapping). The CglUPO gene contains two
introns (the predicted gene model includes a falsely annotated
intron, which excluded resulted in a coding sequence of 780
bp) and encodes a protein of 259 amino acids with a calculated
molecular mass of 29.2 kDa and a theoretical pI of 5.59. Nine
different peptide fragments of CglUPO obtained by peptide
mapping matched perfectly with the deduced amino acid se-
quence (45.95 % sequence coverage). Several conserved amino
acids (e.g. , the proximal heme binding region (PCP motif) and
the distal binding site for a magnesium ion (EHD motif)) were
found in the translated protein sequence (Figure 2).
Figure 1. Time-course of UPO production (circles) by C. globosum in 4.2 %
glucose, 1.8 % soybean peptone, and 0.45 % (w/v) yeast extract. CglUPO
activity was measured with a veratryl alcohol assay at pH 7.[14] Data are
mean:SD from three culture flask assays. The dotted line shows pH.
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CglUPO oxidized typical peroxidase substrates like ABTS
(2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) and DMP
(2,6-dimethoxyphenol) to characteristic radicals and coupling
products, and aryl alcohols such veratryl alcohol and benzyl
alcohol into the corresponding aldehydes (Figure S2). The en-
zyme also catalyzed the H2O2-dependent conversion of naph-
thalene to 1-naphthol (via naphthalene oxide), and of 5-nitro-
1,3-benzodioxole (NBD) to 4-nitrocatechol. This unambiguously
demonstrates its true peroxygenase nature. In general, CglUPO
was active over pH 4.5 to 9 (substantial activity loss outside
this pH range; Figures S2–S4). CglUPO was not capable of oxi-
dizing bromide or chloride, as no bromo- or chlorophenols
were detectable by HPLC after exposure of phenol to UPO in
the presence of the respective halides.
Enzymatic conversion of testosterone
In contrast to the UPOs from A. aegerita (AaeUPO), M. rotula
(MroUPO), Coprinopsis cinerea (rCciUPO), and Humicola insolens
(rHinUPO), which did not convert testosterone, CglUPO accept-
ed testosterone as a substrate (total turnover number (TTN)
7000 under the conditions used). Because of the moderate
turnover number (kcat = 0.26 s
@1), the catalytic efficiency (kcat/
Km = 1.60 V 10
3 s@1m@1) for testosterone was about two orders
of magnitude lower than for the other peroxidase and peroxy-
genase substrates tested (Table S2).
Testosterone (1) was oxidized into two products, 1 a and 1 b,
in the ratio 9:1 (according to LC-MS). Both compounds exhibit-
ed a mass shift of m/z + 16, thus indicating incorporation of
oxygen (Figure S6). Product 1 a lost the UV-absorption charac-
teristics of testosterone and was more hydrophobic (Fig-
ure 3 A), whereas 1 b retained the UV characteristics and dis-
played increased hydrophilicity. In order to determine the
exact structure of the testosterone metabolites, larger amounts
of 1 a and 1 b were enzymatically synthesized starting from
100 mg of 1. The time course of the reaction (Figure 3 B)
shows that the products formed concomitantly and accumulat-
ed in the reaction mixture. After isolation and purification,
65 mg of 1 a and 7 mg of 1 b were obtained (purities >96 %).
13C- and 1H-NMR studies revealed formation of the 4,5-epoxide
of testosterone in b-configuration (17b-hydroxy-4,5-epoxy-5b-
androstan-3-one, 1 a) and 16a-hydroxytestosterone (16a,17b-
dihydroxyandrost-4-en-3-one, 1 b ; Scheme 1). Both oxygena-
tions occurred with high selectivity (diastereomeric ratios
>98 %).
Discussion
The ascomycetous fungus C. globosum (order Sordariales) is
a strong cellulolytic mold and is well known for its ability to
produce various secretory enzymes and secondary metabolites
with a wide range of biological activity.[24] Production of an un-
specific peroxygenase (CglUPO) by this fungus was achieved in
a complex medium rich in carbon and nitrogen. The corre-
sponding UPO sequence was assigned in the genome of the
fungus (GenBank XM_001219539.1) and verified by secretomic
analysis. According to these data, it belongs to the “short”
type UPOs of group I; these lack an internal disulfide bridge.[12]
The purified enzyme catalyzed the oxidation of classic perox-
idase substrates such as ABTS and DMP, it cleaved NBD (deme-
thylenation, a special case of O-dealkylation), and it selectively
incorporated peroxide-borne oxygen into naphthalene and the
bulky gonane structure of testosterone.
CglUPO is the fourth wild-type UPO to be described, and the
first to be isolated from an ascomycetous fungus. The spectral
data of the resting state resemble those of basidiomycetous
Figure 2. Amino acid sequence of the corrected CglUPO protein (XM_
001219539.1). Predicted signal peptide is in italics ; red letters represent pep-
tides identified by peptide mapping; blue letters show putative N-glycosyla-
tion sites; proximal heme-binding region (PCP motif) and distal binding-site
for a magnesium ion (EHD motif) are underlined.
Figure 3. A) HPLC chromatogram and B) time-course of CglUPO-catalyzed
conversion of testosterone (1). Overlaid LC-MS elution profiles were record-
ed at 247 nm for *: testosterone; single ion t [M+H]+ 305 for the products
(~: 1 a, &: 1 b). B displays the reaction progress of the 100 mg approach.
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UPOs (AaeUPO, CraUPO, MroUPO), with the Soret band at
around 420 nm (typical for heme-thiolate proteins including
numerous P450s).[36] The a and b maxima at 570 and 540 nm
are almost identical to the respective bands of reported
UPOs.[12] The molecular mass of CglUPO, 36 kDa, is between
those of AaeUPO (43–46 kDa) and MroUPO (32 kDa). The differ-
ence to the molecular mass calculated on the basis of the
CglUPO gene (29.2 kDa) can be explained by glycosylation
(19 %), as has been demonstrated for all other characterized
UPOs (14–44 %).[12] Four potential N-glycosylation sites (Asn res-
idues) were identified in the amino acid sequence of CglUPO,
thus strongly supporting this assumption (Figure 2). The final
purification step in an anion exchanger (MonoQ column) re-
sulted in two fractions with the same molecular mass, thus
indicating the presence of two isoforms. Isoforms with almost
identical molecular masses were reported for other UPOs (e.g. ,
UPOs of A. aegerita and C. radians) and fungal heme peroxidas-
es (e.g. , manganese peroxidases of Ceriporiopsis subvermis-
pora).[14–16, 37]
A distinctive feature of CglUPO is its relatively poor stability
at acidic pH. AaeUPO and MroUPO are active over a remarkably
broad pH range (pH 2–9), whereas CglUPO showed substantial
activity loss below pH 4.5 (~50 % after 4 h). Thus, the enzyme
is poorly suited to an acidic reaction environment, and, addi-
tionally, its purification by ion exchange chromatography (e.g. ,
on MonoQ columns) is hampered because of the use of acidic
eluents. Another feature of CglUPO is the lack of halogenating
activity. In contrast to AaeUPO and CraUPO, which efficiently
oxidize bromide, CglUPO did not catalyze halide oxidation; in
this context it resembles MroUPO.[14–16] Interestingly, CglUPO
and MroUPO belong to group I UPOs (“short” peroxygenases) ;
however, the strongly halogenating chloroperoxidase (CPO) is
also in the same subfamily.[12]
Without doubt, the oxidation of testosterone is the most re-
markable catalytic feature of CglUPO, by the transfer of perox-
ide-borne oxygen to the gonane ring system. Neither MroUPO,
nor AaeUPO, nor recombinant UPOs (rCciUPO, rHinUPO) were
able to convert testosterone substantially. Recently, this inabili-
ty was proposed to be related to the absence of an alkyl side
chain at C17 (D ring), which is the preferred UPO oxidation site
of steroids, as the bulky cholesteryl caprylate was the only ste-
roid (besides testosterone) that was not attacked (three UPOs
and 15 steroidal substrates).[20] Although AaeUPO, MroUPO,
and rCciUPO preferentially oxidize hydrophobic molecules, in-
cluding relatively bulky substrates,[17, 19, 20, 38] size and geometry
of the gonane core seemingly impedes diffusion of complete
steroid molecules through the heme-access channel to the
active site. In contrast, the substrate channel of CglUPO must
be broader or more flexible, so sterically demanding com-
pounds such as testosterone can enter the active site in a way
that allows correct positioning and subsequent oxygenation.
The conversion of testosterone (1) by CglUPO resulted in the
formation of two oxygenated products : an epoxide (1 a) and
16a-hydroxytestosterone (1 b). The higher hydrophobicity of
1 a (compared to 1) can be explained by the epoxidation of
1 in the 4,5-position, thus altering the spatial structure and ri-
gidity of the steroidal A ring, and in turn the polarity of 1. Ep-
oxidation of the A ring also explains the loss of UV absorption
by 1 a ; this is not typical for oxyfunctionalizations, and led to
the breakup of the chromophoric enone structure of 1. How-
ever, with its additional secondary alcohol functionality, 1 b is
more hydrophilic, and thus has the physicochemical properties
of a typical oxyfunctionalization product. The product ratio
(1 a/1 b, 9:1) might reflect the probability of ring A or ring D of
testosterone entering the heme channel first. A plausible ex-
planation for why CglUPO prefers the oxidation of ring A over
ring D is not currently clear, particularly as other UPOs are not
able to oxidize enone structures.[26, 31] Computational docking
studies or co-crystallization experiments revealing the exact
position of testosterone in the active site of CglUPO could help
to solve this problem. With regard to a shift of the ratio in
favor of D ring hydroxylation, the affinity of the A ring to the
enzyme (and hence the formation of 1 a) could be reduced by
introducing appropriate protective groups (e.g. , acetals,
oximes) into the enone structure. Another approach to alter
the product ratio might be protein engineering, such as ration-
al design (which would require comprehensive structure–func-
tion data, including crystal structures) or directed evolution.
For example, a peroxygenase from A. aegerita was recently en-
gineered for increased selectivity and TTN in the conversion of
naphthalene into 1-naphthol, as well as in a diminished peroxi-
dative activity.[39]
Compound 1 a, a steroid containing a 4,5-epoxy-3-oxo
moiety, is of special relevance for synthetic applications and
biological activities, as epoxy steroids are involved in the regu-
lation of cell proliferation and cholesterol homeostasis.[40] The
synthetic versatility of epoxides has established them as useful
precursors to obtain a variety of polyfunctional derivatives or
rearranged compounds.[41–47] Cyclic a-epoxide enones are
found in a number of natural products, but asymmetric epoxi-
dation of their precursors is notoriously difficult.[48] The synthe-
sis of b-epoxy steroids has been achieved by using different
chemical oxidants, such as chromyl diacetate, potassium per-
manganate salts, chiral ketones combined with oxone, and
transition metal complexes in the presence of molecular
oxygen.[49] Selective biocatalytic oxygen incorporation by UPOs
Scheme 1. Conversion of testosterone (1) by CglUPO to testosterone 4,5b-epoxide (1 a) and 16a-hydroxytestosterone (1 b).
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to form b-epoxides under mild conditions could supplement
these existing chemical methods.
The second product of CglUPO-catalyzed testosterone con-
version, 1 b (16a-hydroxytestosterone), is a metabolite of oxi-
dative steroid metabolism in liver cells. Its formation was
shown to be catalyzed by membrane-bound cytochrome
P450s in human and rat liver microsomes;[50] beyond that, the
hydroxylation of testosterone at the 16a-position is an impor-
tant step in the formation of estriol in late pregnancy.[51, 52]
Soluble P450s of Gram-positive bacteria, such as CYP154C3
from Streptomyces griseus, P450 BM3 (CYP102A1, variant M01
A82W S72I) from Bacillus megaterium, and CYP145C5 from No-
cardia farcinica, were reported to selectively hydroxylate tes-
tosterone and related steroids at the 16a-position.[8, 53, 54] Crude
preparations of the latter enzyme were particularly efficient (as
an isolated P450) and achieved TTNs of 500 to 2300 for this re-
action.[54] We achieved a TTN above 7000 for testosterone oxi-
dation, yet, in contrast to P450s, CglUPO requires neither re-
duced nicotinamide cofactors nor any regenerating system—
hydrogen peroxide alone was sufficient for activation and func-
tion.
If the challenge of heterologous expression of CglUPO in a
suitable host (e.g. , in Aspergillus oryzae, Saccharomyces cerevi-
siae, or Pichia pastoris) can be overcome, a powerful synthetic
tool would be available for the oxyfunctionalization of steroi-
dal structures, and this could be subjected to protein engineer-
ing. Such an approach was recently described for an A. aegerita
UPO that was expressed in S. cerevisiae and mutated in nine
positions, and then optimized for recombinant protein produc-
tion and secretion in P. pastoris.[25, 55, 56] Moreover, modern pro-
tein engineering techniques might help to design tailor-made
UPOs for specific steroid hydroxylations and to overcome cata-
lytic bottlenecks such as solvent and peroxide instability. Con-
cerning reaction design, UPO immobilization (for example, by
encapsulation) and gentle co-substrate generation will contrib-
ute to improved CglUPO performance.[11, 57] These and other
approaches are currently under investigation.
Experimental Section
Material and reagents: Testosterone (17b-hydroxy-4-androsten-3-
one), yeast extract, ABTS and naphthalene were purchased from
AppliChem (Arheilgen, Germany); H2O2 (30 % w/v), soybean pep-
tone, agar, a-d-glucose, benzyl alcohol, phenol, and sodium azide
were from Carl Roth; malt extract, 2-chlorophenol, and 4-chloro-
phenol were obtained from Merck; glucose oxidase from Aspergil-
lus niger was purchased from Sigma–Aldrich (specific activity
215 U mg@1). All other chemicals were purchased from Sigma–Al-
drich at the highest purity available.
Peroxygenases of A. aegerita (AaeUPO) and M. rotula (MroUPO)
were produced and purified as described previously;[14, 16] recombi-
nant UPOs from C. cinerea (rCciUPO) and H. insolens (rHinUPO =
rNovo) were gifts from Novozymes A/S (Copenhagen, Den-
mark).[25–28]
The specific activities of AaeUPO and MroUPO were 63.5 U mg@1
and 48.1 U mg@1, respectively (1 U is the oxidation of 1 mmol vera-
tryl alcohol to veratraldehyde per 1 min at 23 8C).[14]
Cultivation of C. globosum : C. globosum (strain DSM 62110) was
purchased from the German Collection of Microorganisms and Cell
cultures (Braunschweig, Germany) and was routinely grown on
malt extract agar medium (malt extract (20 g L@1) and agar
(15 g L@1)) at 24 8C. For enzyme production, the fungus was cul-
tured in 500 mL Erlenmeyer flasks containing carbon- and nitro-
gen-rich basic liquid medium (200 mL; glucose (42 g L@1), peptone
(18 g L@1), yeast extract (4.5 g L@1) in deionized water) on a rotary
shaker (120 rpm) at 24 8C for four weeks. Liquid cultures were ino-
culated with a mycelial suspension (5 % v/v) obtained by homoge-
nization of the content of two agar plates fully covered with
fungal mycelium in sterile sodium chloride (100 mL, 0.9 % w/v).
Enzyme assays: UPO activities were measured photometrically by
monitoring the oxidation of veratryl alcohol (5 mm) into veratralde-
hyde at 310 nm (e310 = 9300 m
@1 cm@1) in McIlvaine buffer at
pH 7.[14] Reaction was started by the addition of hydrogen peroxide
(2 mm). Laccase activity during cultivation was determined by the
oxidation of ABTS to the corresponding ABTS cation radical at
420 nm (e420 = 36 000 m
@1 cm@1) in McIlvaine buffer at pH 4.5 in the
absence of H2O2.
[29] The specific ring-hydroxylating activity of
CglUPO was monitored by the oxygenation of naphthalene (1 mm)
to naphthalene oxide and 1-naphthol at 303 nm (e303 =
2030 m@1 cm@1) in McIlvaine buffer at pH 6.0; the reaction was start-
ed by adding hydrogen peroxide (2 mm).[30]
Purification and characterization of CglUPO: All purification steps
were carried out at room temperature. Enzyme fractions were as-
sayed for UPO activity, and protein content was determined with
a Pierce BCA protein assay kit (Thermo Fisher) with bovine serum
albumin as standard. Protein purification was carried out by using
ammonium sulfate precipitation and fast protein liquid chromatog-
raphy (FPLC) on Q-Sepharose FF (IEC), Superdex75 (SEC), and
Mono Q columns (IEC), successively. All chromatographic steps
were accomplished with an gKTA purifier FPLC system (GE Health-
care).
The molecular mass of purified CglUPO was analyzed by SDS-PAGE
by using a 10 % Bolt Bis-Tris Gel (Thermo Fisher Scientific). The sep-
arated protein bands were visualized with a Colloidal Blue Staining
Kit (Generon Ltd, Berkshire, UK, order code GEN-QC-Stain-1L); a
protein marker (#26616, Thermo Fisher Scientific) was used as stan-
dard.
Proteomic enzyme identification was performed at the Helmholtz-
Centre for Environmental Research—UFZ, Department of Molecular
Systems Biology (Leipzig, Germany). For detailed information (pep-
tide mapping), see the Supporting Information.
Kinetic constants (Km, kcat) of CglUPO and pH optima were deter-
mined for veratryl alcohol, benzyl alcohol, DMP, ABTS, NBD
(pH 7),[31] and naphthalene (pH 6; Supporting Information). Halo-
genating activity was tested by incubating CglUPO (0.2 U mL@1,
0.46 mm) in potassium phosphate buffer (100 mm, pH 3 and pH 7)
in the presence of phenol (0.1 mm), potassium bromide or chloride
(10 mm) and H2O2 (2 mm).
[32] After 10 min, the reaction mixture
was analyzed by HPLC for the formation of bromo- and chlorophe-
nols against authentic standards.
Enzymatic conversion of testosterone: The reaction mixture (total
volume 0.5 mL) contained purified AaeUPO (2 U mL@1, 0.7 mm),
MroUPO (2 U mL@1, 1.3 mm) or CglUPO (0.2 U mL@1, 0.46 mm) in po-
tassium phosphate buffer (20 mm, pH 7) with testosterone (5 mm),
a-d-glucose (2 %, w/v), and acetone (5 %, v/v). Reactions were start-
ed by addition of glucose oxidase (GOx, 0.02 U mL@1) and stirred at
room temperature for 24 h (after this time, no residual activity of
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CglUPO was detectable). Kinetic data were determination for
CglUPO (2 U mL@1, 4.8 mm) with testosterone (5 mm) in potassium
phosphate buffer (20 mm, pH 7). Reactions were initiated by the
addition of hydrogen peroxide (2 mm) and stopped after 2 min by
adding sodium azide (1 mm). Higher concentrations of hydrogen
peroxide were not applied, in order to prevent enzyme inactivation
from heme bleaching and the disproportionate increase in the
UPO intrinsic catalase activity (both have been reported for other
UPOs and heme peroxidases).[33–35] Products were recovered with
reversed-phase SPE cartridges (Strata-X 33u, Phenomenex), with
elution in methanol, and analyzed by HPLC.
At preparative scale, a 500 mL flask was filled with testosterone
(100 mg, 0.35 mmol), acetone (10 mL), water (140 mL), potassium
phosphate buffer (40 mL 0.1 m, pH 7), and CglUPO stock solution
(20 mL 400 U in potassium phosphate buffer (0.1 m, pH 7)). The re-
action mixture was stirred at room temperature while hydrogen
peroxide (100 mm, 4 mL h@1) was continuously supplied by a sy-
ringe pump. Hydrogen peroxide was used instead of glucose/GOx,
in order to ensure constant peroxide dosage and to avoid impuri-
ties in the reaction mixture (glucose and gluconolactone); the sy-
ringe pump system was as effective as the GOx-based H2O2 gener-
ation system. Samples (50 mL) were taken from the reaction mix-
ture every 30 min, and the reaction (in the samples) was stopped
by adding acetonitrile (50 mL) and sodium azide (10 mL, 10 mm).
The samples were centrifuged, and the supernatants were ana-
lyzed by HPLC (below). After 7 h, thin layer chromatography (in
ethyl acetate/n-hexane, 9:1) indicated complete conversion of tes-
tosterone. The reaction mixture was extracted three times with
ethyl acetate (50 mL), then the combined organic fractions were
dried with Na2SO4 and evaporated to dryness to give 91 mg of
crude products 1 a (Rf 0.67) and 1 b (Rf 0.11). The compounds were
purified by chromatography on silica gel with ethyl acetate/n-
hexane (9:1) as the eluent to obtain 65 mg (61.1 %) of 1 a (96.3 %
purity) and 7 mg (6.6 %) of 1 b (98.7 % purity).
Analytical methods: The HPLC-MS system (Waters) comprised a
2690 separation module, a 2996 photo diode array detector, and
a Micromass ZMD 2000 single quadrupole mass spectrometer. Sep-
aration was on a LiChrospher C18 column (125 V 4 mm, 5 mm, Phe-
nomenex) with mobile phases A (formic acid (0.1 %)) and B (aceto-
nitrile) and at stepwise gradient (20 % B (3 min), increase to 55 % B
(20 min), increase to 90 % B (3 min)). The final level was maintained
until all analytes had been eluted from the column (flow-rate
1 mL min@1, column temperature 30 8C). Reaction products were
identified by comparison to authentic standards based on reten-
tion time, UV absorption spectrum and mass spectra [M+H]+ or
[M@H]@ ions, and quantified by total peak area by using response
factors of the same or similar compounds. Data from replicates
were averaged. Standard deviations were below 5 % of the mean
in all cases.
1H (400 MHz) and 13C (100 MHz) NMR spectra of testosterone and
its enzymatic conversion products were obtained on Bruker spec-
trometer (Bruker Avance II 400 MHz) in the solvent indicated.
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